The Form 4 filing for Brad Berryman was submitted on November 19, 2026. Form 4 is the SEC report used to disclose insider stock activity. The sales took place on November 17, 2026, two days before the filing.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-17 |
| Date of Latest Transaction | 2026-11-17 |
| Buy/Sell | sell |
| Transaction Count | 19 |
| Shares Transacted | 56,091 |
| Price | $353.50 |
| Total Transaction Value | $19,828,299.79 |
| Insider | |
| Ticker Symbol | TLN |
| Company | Talen Energy Corp |
| Insider Name | Berryman Brad |
| Insider Title | Chief Operating Officer |
| Sector - Industry | Utilities - Utilities - Independent Power Producers |
| Holdings | |
| Total Shares Owned After Transaction | 11,638 |
| Position Size Change | 82.82% |
| Filing | |
| Filing Date | 2026-11-19 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were sales of Talen Energy (TLN) shares, reported under SEC transaction code S. The record covers one insider and one filing, with 19 sale transactions.
What was the average price of the transaction?
The average sale price was $353.50 per share across the 19 transactions.
How did this transaction affect the insider's holdings?
Brad Berryman sold 56,091 shares and reported 11,638 shares owned afterward. The sales covered 82.82% of the shares he owned before the trades.
What's the total transaction value?
The total value was $19,828,299.79 across all 19 sales. This is rounded to cents from the more precise value of $19,828,299.786.
Are there any special circumstances around this transaction?
The filing information includes a Rule 10b5-1 reference or checkbox. These trading plans set instructions in advance. Footnote text was not available to confirm which of the 19 sales a plan covered. The reference may apply to the filing as a whole rather than each sale. The plan's start date and trading schedule are also unknown. A plan reference alone does not show whether the trades met the rule's legal requirements.
For research purposes only; not investment advice.